Tata Chemicals Limited
National Stock Exchange of IndiaTotal Valuation
Tata Chemicals Limited carries a market capitalization of 177.35B, placing it among publicly traded companies globally. Its enterprise value stands at 238.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 177.35B |
| Enterprise Value | 238.90B |
Valuation Ratios
Tata Chemicals Limited trades at a trailing price-to-earnings ratio of 70.89.
| PE Ratio | 70.89 |
| PS Ratio | 1.61 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Tata Chemicals Limited trades at an EV/EBITDA multiple of 26.60 and an EV/FCF ratio of 51.19. The EV/Sales ratio of 1.61 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.60 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.61 |
| EV / EBITDA | 26.60 |
| EV / EBIT | 26.60 |
| EV / FCF | 51.19 |
Financial Position
Tata Chemicals Limited maintains a current ratio of 2.22, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 59.46, indicating elevated leverage, while an interest coverage ratio of 1.56 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.22 |
| Quick Ratio | 0.45 |
| Debt / Equity | 59.46 |
| Debt / EBITDA | N/A |
| Interest Coverage | 1.56 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -0.11 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Tata Chemicals Limited has paid 1.17B in income taxes, reflecting an effective tax rate of 19.12.
| Income Tax | 1.17B |
| Effective Tax Rate | 19.12 |
Stock Price Statistics
Tata Chemicals Limited's stock has declined approximately -25.08071% over the past 52 weeks. The 50-day moving average sits at 749.09, while the 200-day moving average is 758.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | -25.08071% |
| 50-Day Moving Average | 749.09 |
| 200-Day Moving Average | 758.03 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tata Chemicals Limited generated 148.17B in revenue and converted that into 3.37B in net income, yielding earnings per share of 19.41. EBITDA reached 8.98B, while operating income came in at 8.98B.
| Revenue | 148.17B |
| Gross Profit | 115.51B |
| Operating Income | 8.98B |
| Pretax Income | 6.12B |
| Net Income | 3.37B |
| EBITDA | 8.98B |
| EBIT | 8.98B |
| Earnings Per Share (EPS) | 19.41 |
Margins
Tata Chemicals Limited operates with a gross margin of 77.96, reflecting its pricing power and cost economics. The operating margin of 6.06 and net profit margin of 2.27 provide insight into operational efficiency.
| Gross Margin | 77.96 |
| Operating Margin | 6.06 |
| Pretax Margin | 4.13 |
| Profit Margin | 2.27 |
| EBITDA Margin | 6.06 |
Scores
Tata Chemicals Limited posts an Altman Z-Score of 3.91, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.91 |